Charitharth Vivek Lal, MD (he/him/his)

Director of Clinical Innovation, MH Institute of Biomedical Innovation
University of Alabama at Birmingham

Poster(s):

• 432 - A Live Biotherapeutics Product Reverses Neutrophilic Inflammation and Disease Phenotype in Models of Bronchopulmonary Dysplasia
  Monday, April 25, 2022

  3:30 PM – 6:00 PM US MT

• 480 - Hospital and Neurodevelopmental Outcomes in Nano-Preemie Infants Receiving Invasive Vs. Non-invasive Ventilation at Birth
  Saturday, April 23, 2022

  3:30 PM – 6:00 PM US MT

• 313 - Impact of Cytomegalovirus (CMV) infection and exposure at the Maternal-Fetal Interface.
  Friday, April 22, 2022

  6:15 PM – 8:45 PM US MT

• 474 - Association of Mycoplasma and Ureaplasma Respiratory Colonization and Bronchopulmonary Dysplasia in Extremely Preterm Infants- A Propensity Score Matched Case-Control Study
  Monday, April 25, 2022

  3:30 PM – 6:00 PM US MT